Wallace DJ, Ginzler EM, Merrill JT, et al. Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE. EULAR 2017, #OP0232.
Cardiovasculaire risicofactoren bij primair syndroom van Sjögren
jan 2024 | Ritmestoornissen, Sjögren